By highlighting ATAD2’s central roles in oncogenic signaling, chromatin remodeling, and drug resistance, this review emphasizes its potential as a critical therapeutic target, aiming to motivate medicinal chemists, pharmacologists, cancer biologists, and other researchers to advance ATAD2-focused drug discovery and translational studies. The gene discussed is ATAD2; the disease is cancer.